Rahul Singhvi, Resilience CEO
June 8, 2022 02:28 PM EDT
Deals
Manufacturing

Re­silience nets an­oth­er deal, this time with bil­lion­aire’s can­cer re­search cen­ter

Tyler Patchen

News Reporter

Re­silience is hav­ing a fun week. Fresh off a $625 mil­lion Se­ries D and the launch of a joint ven­ture with MD An­der­son …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Shell com­pa­ny Con­cen­tra has found its rhythm, with Car­go Ther­a­peu­tics as its lat­est buy­out tar­get

FDA chief calls for 'mean­ing­ful' re­duc­tion of an­i­mal test­ing for new drugs

Trump's tax cut law ex­pands or­phan drug ex­clu­sions, could up­end 340B pro­gram

Sin­ga­pore­an biotech gets Chi­na thumbs-up for study of po­ten­tial­ly cu­ra­tive HBV cell ther­a­py

No­var­tis maps launch of malar­ia drug for new­borns af­ter Swiss ap­proval

sponsored

Un­cov­er­ing the Po­ten­tial of Tar­get­ing the CD38 Path­way for Im­mune-Me­di­at­ed Dis­eases

A service from the Financial Times